Cannabis ETF (THCX)

The U.S. cannabis industry continues to expand rapidly, making ancillary stocks an attractive area for investors. In 2024, legal cannabis sales reached more than $29 billion nationwide. Analysts proje...

The U.S. cannabis industry continues expanding at a rapid pace. In 2024, legal sales reached nearly $30 billion nationwide. Analysts now project the market could surpass $45 billion by 2028. This grow...

In the last 3-6 months, most marijuana stocks have gone from bottom prices to an upward swing. For a long while, the sector has fallen and lain dormant. This led to much fear and doubt among some shar...

Trump's marijuana rescheduling remarks reignite cannabis optimism, putting Village Farms, Canopy Growth and High Tide in focus.

A fairly consistent climb in Tilray Brands' NASDAQ: TLRY stock price has started to capture the market's attention. After touching a 52-week low of 35 cents, the stock has rallied dramatically, climbi...

The U.S. cannabis industry continues to evolve as legalization momentum builds and consumer demand rises. Investors remain focused on companies with significant retail presence and brand strength. Des...

It's happening again. The cycle of pot stocks surging on news related to potential cannabis reform.

Cannabis ETF spent the first half of the year in the performance doldrums. But they have rallied of late on news that the Trump administration is open to reclassifying marijuana as a less dangerous dr...

The cannabis REIT sector continues to attract attention from income-focused investors this week. The US cannabis industry generated nearly $36 billion in legal sales in 2024. Furthermore, analysts pro...

Canada's leading cannabis firms with U.S. exposure are gaining fresh attention. Their ability to bridge both markets gives them an advantage. Moreover, U.S. policy shifts could provide new momentum. R...